Clinical Trials on 체세포 HER2 또는 EGFR 엑손 18 돌연변이를 품고 있는 고형 종양 in Hong Kong
총 1 건
-
Taiho Oncology, Inc.모병표피 성장 인자 수용체(EGFR) 엑손 20 삽입(ex20ins) 돌연변이가 있는 진행성 또는 전이성 NSCLC미국, 일본, 스페인, 프랑스, 호주, 이탈리아, 대한민국, 영국, 캐나다, 독일, 칠면조, 홍콩
이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.
스폰서 및 공동 작업자
- CCSRM - Clinical Center for Studies in Regenerative Medicine
- Ankara Diskapi Training and Research Hospital
- Dept. of thoracic Surgery
- Fundacio Puigvert
- Cardiovascular Research Foundation, New York
- Arnavutkoy State Hospital
- Say-June Kim
- VISN 3 Mental Illness Research, Education and Clinical Center
- Leicester City Clinical Commissioning Group
- Hämatologisch-Onkologische Schwerpunktpraxis, Münster, Germany
- Hexigten Banner Mongolian Traditional Chinese Medicine Hospital
- Paris Translational Research Center for Organ Transplantation
- Bartosz of Zurowski
- The Huazhong University of Science and Technology Union Shenzhen Hospital
- Prism Research LLC
- Frantisek Duska, MD, PhD
- VoiceSense Ltd. Herzelba, Israel
- Xijing hospital of air force Medical University
- LB Pharmaceuticals Inc.
- Volunteer Hamilton
- 전체 목록보기
CROs by country
- Contract Research Organizations in Australia
- Contract Research Organizations in Brazil
- Contract Research Organizations in Burkina Faso
- Contract Research Organizations in Canada
- Contract Research Organizations in Guinea
- Contract Research Organizations in Hong Kong
- Contract Research Organizations in Lebanon
- Contract Research Organizations in Malaysia
- Contract Research Organizations in Malta
- Contract Research Organizations in Panama
- Contract Research Organizations in United Kingdom
- Contract Research Organizations in United States
- Contract Research Organizations in Zimbabwe
- CRO list by country